Cerrato, Giulia
Alvarez-Lucena, Carlota http://orcid.org/0000-0002-7115-2111
Sauvat, Allan http://orcid.org/0000-0001-7076-8638
Hu, Yanhua
Forveille, Sabrina
Chen, Guo http://orcid.org/0000-0001-5354-3816
Durand, Sylvère
Aprahamian, Fanny
Leduc, Marion
Motiño, Omar http://orcid.org/0000-0002-3858-0966
Boscá, Lisardo http://orcid.org/0000-0002-0253-5469
Xu, Qingbo http://orcid.org/0000-0002-6414-2273
Kepp, Oliver http://orcid.org/0000-0002-6081-9558
Kroemer, Guido http://orcid.org/0000-0002-9334-4405
Article History
Received: 20 July 2023
Revised: 30 October 2023
Accepted: 13 November 2023
First Online: 22 November 2023
Competing interests
: OK is a cofounder of Samsara Therapeutics. GK has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys, and Vascage. GK is in the scientific advisory boards of Hevolution, Institut Servier and Longevity Vision Funds. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. GK is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis and metabolic disorders. GK’s wife, Laurence Zitvogel, has held research contracts with 9 Meters Biopharma, Daiichi Sankyo, Pilege, was on the on the Board of Directors of Transgene, is a cofounder of everImmune, and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. GK’s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim.
: All animal experiments were approved by Ethical Committee of the Gustave Roussy Campus Cancer (CEEA IRCIV/IGR no. 26, registered at the French Ministry of Research), the institutional committee of the department of laboratory animals, Central South University; approval reference No. 2021/159 and were in agreement with the EU Directive 2010/63 and Recommendation 2007/526/EC, enforced by the Spanish law under the Real Decreto 53/2013 (PROEX number 42.8/23).